Esperion Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 01:20PM GMT
Jeff Hung - Morgan Stanley, Research Division - Equity Analyst

Good morning. Welcome to the Morgan Stanley Global Healthcare Conference. I'm Jeff Hung, one of the biotech analysts. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

For this session, we have Esperion with CEO, Sheldon Koenig. Welcome, Sheldon.

Sheldon L. Koenig - Esperion Therapeutics, Inc. - President, CEO & Director

Hey, Jeff. Thank you. Great to be here.

Jeff Hung - Morgan Stanley, Research Division - Equity Analyst

For those who may not be familiar with Esperion, can you provide a brief introduction?

Sheldon L. Koenig - Esperion Therapeutics, Inc. - President, CEO & Director

Yes, absolutely. First of all, on behalf of Esperion and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot